These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 15999364)
1. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364 [TBL] [Abstract][Full Text] [Related]
2. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370 [TBL] [Abstract][Full Text] [Related]
3. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma. Kao RH; Huang LC; Hsu YH Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040 [TBL] [Abstract][Full Text] [Related]
4. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Chang HW; Chow V; Lam KY; Wei WI; Yuen A Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224 [TBL] [Abstract][Full Text] [Related]
5. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma]. Zhou YN; Xu CP; Han B; Ji R Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136 [TBL] [Abstract][Full Text] [Related]
6. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Etoh T; Kanai Y; Ushijima S; Nakagawa T; Nakanishi Y; Sasako M; Kitano S; Hirohashi S Am J Pathol; 2004 Feb; 164(2):689-99. PubMed ID: 14742272 [TBL] [Abstract][Full Text] [Related]
7. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Yeh KT; Shih MC; Lin TH; Chen JC; Chang JY; Kao CF; Lin KL; Chang JG Anticancer Res; 2002; 22(6C):3971-5. PubMed ID: 12553020 [TBL] [Abstract][Full Text] [Related]
8. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer]. Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596 [TBL] [Abstract][Full Text] [Related]
9. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Kim H; Kwon YM; Kim JS; Han J; Shim YM; Park J; Kim DH Cancer; 2006 Sep; 107(5):1042-9. PubMed ID: 16888795 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression. Gao P; Yang X; Xue YW; Zhang XF; Wang Y; Liu WJ; Wu XJ Cancer; 2009 Jul; 115(14):3222-32. PubMed ID: 19484794 [TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
15. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Saito T; Nishimura M; Yamasaki H; Kudo R Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599 [TBL] [Abstract][Full Text] [Related]
19. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma. Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]